KARMET (ENT-01-030) - Efficacy of Orally Administered ENT-01 for the Treatment of Parkinson’s Disease-Related Constipation

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study to Evaluate Safety, Tolerability and Efficacy of Orally Administered ENT-01 for the Treatment of Parkinson’s Disease-Related Constipation

Recruitment Information:

Seeking volunteers with following diagnosis: PD, Control Volunteers Accepted Study Type: Interventional
Eligible Ages: 30 - 86 Status: Recruiting
Time Since Diagnosis: 6 years or more Study Focus: Constipation/Bladder Problems

Study Purpose:

To evaluate the safety, tolerability, and efficacy of repeated oral doses of ENT-01 for up to 25 days in subjects with Parkinson’s Disease-related constipation.

Find a Site Location and Contact the Trial Team

More Details

Patients will be randomized to active investigational treatment or placebo, and followed for approximately 70 days. Patients will have 6 visits to the clinic.

Phase: Phase 2 Lead Sponsor: Enterin, Inc
Trial ID: 006158 Sponsor Type: Industry
Primary Country: United States Additional Collaborators or Sponsors: N/A
Estimated Enrollment: 72 Study Start Date: December 2018
Estimated Study Completion Date: July 2019 Source:
Study Website:

More Inclusion & Exclusion Criteria

Share This Trial


Fox Trial Finder strives to make all trial postings as accurate and complete as possible. If you believe any of the information on this page is not accurate, click here to contact us. Thank you for your support.

Choose your location

Please select a Trial Location.
x

Confirmation

You have favorited this trial!

This trial will be listed in the "Favorites" category of your dashboard.
x

Confirmation

You are not interested.

This trial will be listed in the "Not Interested" category on your dashboard. You can click "Interested" if you change your mind.
x

Message to Trial Coordinator

Your message was sent.

Your message was sent to the trial team at the location you selected. Check your dashboard for a response.

Login to My Trial Finder

Please enter your email address and password to access your My Fox Trial Finder dashboard.



*indicates required field.
x

Contact Fox Trial Finder

What best describes you?





*indicates required field.
x